Your shopping cart is currently empty

GNE-783 is a highly selective CHK1 inhibitor that effectively enhances the antitumor efficacy of gemcitabine. After DNA damage, it inactivates S-phase and G2-phase cell cycle checkpoints, thereby improving the therapeutic effect of antimetabolite DNA-damaging agents. GNE-783 shows selective chemosensitization in different tumors, such as enhancing the antitumor activity of temozolomide only in melanoma cell lines.

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 25 mg | $1,820 | 1-2 weeks | 1-2 weeks | |
| 50 mg | $2,380 | 1-2 weeks | 1-2 weeks | |
| 100 mg | $3,100 | 1-2 weeks | 1-2 weeks |
| Description | GNE-783 is a highly selective CHK1 inhibitor that effectively enhances the antitumor efficacy of gemcitabine. After DNA damage, it inactivates S-phase and G2-phase cell cycle checkpoints, thereby improving the therapeutic effect of antimetabolite DNA-damaging agents. GNE-783 shows selective chemosensitization in different tumors, such as enhancing the antitumor activity of temozolomide only in melanoma cell lines. |
| Molecular Weight | 368.43 |
| Formula | C22H20N6 |
| Cas No. | 1200127-66-7 |
| Smiles | N#CC1=NC=C2NC3=NC=C(C=C3C2=C1)C=4C=CC(=CC4)N5CCN(C)CC5 |
| Relative Density. | 1.37 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.